<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03726346</url>
  </required_header>
  <id_info>
    <org_study_id>CIA 243</org_study_id>
    <nct_id>NCT03726346</nct_id>
  </id_info>
  <brief_title>The Evaluation of the Toffee Mask for the Treatment of Obstructive Sleep Apnea</brief_title>
  <official_title>The Evaluation of the Toffee Mask for the Treatment of Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is a prospective, non-randomized, non-blinded study. This investigation is
      designed to evaluate the performance, comfort and ease of use of the F&amp;P Toffee mask amongst
      Obstructive Sleep Apnea (OSA) patients. Up to 45 OSA patients will be recruited from the
      Pulmonary Disease Specialists Research database.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Visit 1 will involve the participants being consented into the trial. Visit 2 will involve
      the participants being fitted with the F&amp;P Toffee mask for use in home. The participant will
      then come in to return the mask (Visit Three) and have a final interview, this ensures the
      maximum time participants will be exposed to the Toffee mask in home will be 14 ± 4 days from
      visit two. The mask will be returned to the Institution at the conclusion of the trial and
      the participant will return to their previous mask. The Institution will recruit all patients
      within 2 weeks of the beginning of the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 26, 2018</start_date>
  <completion_date type="Actual">December 13, 2018</completion_date>
  <primary_completion_date type="Actual">December 13, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Toffee Mask Acceptability</measure>
    <time_frame>14±4 days in home</time_frame>
    <description>Determined from questionnaires-Subjective</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Toffee Mask Comfort</measure>
    <time_frame>14±4 days in home</time_frame>
    <description>Determined from questionnaires-Subjective</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Toffee Mask Treatment Performance-Subjective</measure>
    <time_frame>14±4 days in home</time_frame>
    <description>Determined from questionnaires-Subjective</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Toffee Mask Treatment Performance-Objective</measure>
    <time_frame>14±4 days in home</time_frame>
    <description>Objective data recorded from PAP device- Objective</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Toffee Full Face Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be placed on this arm for a total of 14+- 4 days from visit 2. Participants will be using the Toffee mask during this treatment arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Toffee Full Face Mask</intervention_name>
    <description>Participants will be placed on this arm for a total of 14+- 4 days from visit 2. Participants will be using the Toffee mask during this treatment arm.</description>
    <arm_group_label>Toffee Full Face Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult (22+ years of age)

          -  Able to give informed consent

          -  Apnea hypopnea Index (AHI) ≥ 5 on diagnostic night

          -  Either prescribed Automatic positive airway pressure (APAP), Continuous positive
             airway pressure (CPAP) or Bi-level positive airway pressure (PAP) for OSA

          -  Fluent in spoken and written English

          -  Existing OSA mask user

        Exclusion Criteria:

          -  Inability to give informed consent

          -  Participant intolerant to PAP

          -  Anatomical or physiological conditions making PAP therapy inappropriate

          -  Current diagnosis of respiratory disease or carbon Dioxide (CO2) retention

          -  Pregnant or may think they are pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Goodwin</last_name>
    <role>Study Director</role>
    <affiliation>Research Director</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas O'Brien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pulmonologist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pulmonary Disease Specialists</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>34741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <disposition_first_submitted>April 7, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>March 29, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 3, 2020</disposition_first_posted>
  <last_update_submitted>March 29, 2020</last_update_submitted>
  <last_update_submitted_qc>March 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

